Findings suggest that prior immune experience could affect the course of patient’s diseaseContinue reading
Author Archive: AZBio
Align Technology Establishes New Global Corporate Headquarters In Tempe, Arizona
San Jose, California Campus Becomes West Coast Regional Headquarters and New Digital Innovation CenterContinue reading
Opportunty Alert: EMERGEAZ Fast Grants
In partnership with the Arizona Governor’s Office, invisionAZ and StartupAZ are offering financial support to the state’s startups through the EMERGEAZ Fast Grant. Local entrepreneurs and startups with emerging technologies designed to address the impacts of the pandemic are encouraged to apply. There is a total of $1 million in the fund and grants will be awarded in amounts ranging from $25,000 to $50,000.Continue reading
Governor Ducey’s Budget Focuses On Education, Tax Relief
News Release: January 15, 2021
Budget Also Invests In Public Health, Public Safety, Infrastructure And Wildfire PreventionContinue reading
FDA Releases Final Rule on the Safer Technologies Program for Medical Devices (STeP)
The FDA is introducing a new, voluntary program for certain medical devices and device-led combination products1 that are reasonably expected to significantly improve the safety of currently available treatments or diagnostics that target an underlying disease or condition associated with morbidities and mortalities less serious than those eligible for the Breakthrough Devices Program.
Learn about the Safer Technologies Program for Medical Devices (STeP) program
Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicine
January 13, 2021 — Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.
BIO Announces New Interactive Opportunities to Showcase Your Company
The new Innovation Stage is a must-attend forum provides the best opportunity for leading global innovators, regional economic development groups, patient groups and more to showcase new global biotech insights, build global connections and identify business prospects as a primer to partnering ahead of BIO Digital Week.
Dr. Laurence Hurley Inducted into the National Academy of Inventors
University of Arizona Health Sciences faculty member Laurence Hurley, PhD, professor emeritus in the College of Pharmacy, has been elected as fellow of the National Academy of Inventors (NAI). The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.Continue reading
Life365 Recognized for Innovation
SCOTTSDALE, AZ — January 12, 2021 — Life365 has been named a winner in the 2021 BIG Innovation Awards presented by the Business Intelligence Group. Continue reading
CMS Releases Final Rule on Medicare Coverage of Innovative Technology (MCIT)
The CMS rule the establishes a new coverage pathway – MCIT – for breakthrough medical technologies.